Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

COVID-19: Answering the Questions, Part 1

Source: COVID-19 Comprehensive Resource Center
In Part 1 of this ongoing 12-part COVID-19 series, listen to a brief update on the latest incidence trends, the role of serology in disease assessment, and newly published data on evidence-based antiviral therapy for severe disease followed by answers to critical clinician questions on COVID-19 transmission, diagnosis, and management from frontline provider Vikramjit Mukherjee, MD.
Vikramjit Mukherjee, MD
Released: June 5, 2020

Podcast Notes

In this episode, Part 1 of an ongoing 12-part COVID-19 series, Vikramjit Mukherjee, MD, provides a brief update on the latest incidence trends, the role of serology in disease assessment, and newly published data from the ACTT-1 trial comparing remdesivir vs placebo for severe COVID-19 treatment. After the update, Dr. Mukherjee answers critical clinician questions on COVID-19 transmission, diagnosis, and management. 

Content based on an online CME program supported by an independent educational grant from Gilead Sciences.

Link to full program: https://www.clinicaloptions.com/infectious-disease/programs/covid19-resources

Acknowledgements

Provided by Clinical Care Options, LLC
Contact Info

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Educational grant provided by
Gilead Sciences, Inc.

Information on this Educational Activity

Faculty

Vikramjit Mukherjee, MD

Assistant Professor of Medicine
Division of Pulmonary, Critical Care, & Sleep Medicine
New York University School of Medicine
Director, Medical Intensive Care Unit
Bellevue Hospital
New York, New York

Vikramjit Mukherjee, MD, has no relevant conflicts of interest to report.

Staff

Jennifer Blanchette, PhD

Senior Scientific Director

Jennifer Blanchette, PhD, has no relevant conflicts of interest to report.
Edward King, MA

Executive Vice President

Edward King, MA, has no relevant conflicts of interest to report.
Tiffany Hensley-McBain, PhD

Scientific Director

Tiffany Hensley-McBain, PhD, has no relevant conflicts of interest to report.

Program Medium

This program has been made available online.

Related Content

Dr. Roger Paredes reviews safety and efficacy data on COVID-19 vaccines and considerations for vaccine rollout from Clinical Care Options (CCO)

Roger Paredes, MD, PhD Released: January 7, 2021

Vikramjit Mukherjee, MD, provides a brief update on COVID-19 and answers clinician questions in the CCO Infectious Disease podcast

Vikramjit Mukherjee, MD Released: December 31, 2020

Review frequently asked questions and answers from expert CCO faculty on rapidly evolving data on COVID-19 vaccines and immunity

Jens D. Lundgren, MD, DMSc Vikramjit Mukherjee, MD Released: December 29, 2020

In this concise presentation, Professor Yee-Sin Leo reviews COVID-19 vaccine hesitancy data, and the factors that impact vaccine hesitancy.

Leo Yee-Sin, MBBS, MPH, MRCP, FRCP, FAMS Released: December 24, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue